TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Christi Waarich
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference

Cogent Biosciences will participate in the Jefferies Global Healthcare Conference in London, presenting a live webcast about their precision therapies for genetically defined diseases, with a focus on their lead clinical program bezuclastinib.

Insights
COGT   positive

Company is actively developing targeted therapies, presenting at a global healthcare conference, and expanding research into multiple genetic disease areas